干扰素γ介导噬血细胞综合征血细胞减少的机制研究

doi:10.3969/j.issn.1006-7795.2014.05.004

首都医科大学学报 ›› 2014, Vol. 35 ›› Issue (5): 545-550.doi: 10.3969/j.issn.1006-7795.2014.05.004

干扰素γ介导噬血细胞综合征血细胞减少的机制研究

汤然, 王旖旎, 张嘉, 李硕, 王昭

首都医科大学附属北京友谊医院血液内科, 北京 100050

收稿日期:2014-08-25 出版日期:2014-10-21 发布日期:2014-10-20
通讯作者: 王旖旎 E-mail:zhaowww263@yahoo.com
基金资助:
国家自然科学基金（81000200），北京市卫生系统高层次卫生技术人才培养项目（2011-3-092），首都医科大学基础临床合作研究基金（12JL28）。

Mechanism of interferon gamma mediated hemophagocytic syndrome blood cell reduction

Tang Ran, Wang Yini, Zhang Jia, Li Shuo, Wang Zhao

Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

Received:2014-08-25 Online:2014-10-21 Published:2014-10-20
Supported by:
This study was supported by National Natural Science Foundation of China(81000200), Beijing Health and Technical Personal of High level Plan(2011-3-092), Basic-clinic Cooperative Foundation of Capital Medical University(12JL28).

摘要/Abstract

摘要：

目的探讨噬血细胞综合征患者与正常人骨髓CD34⁺细胞质量的差异情况，研究干扰素γ对骨髓分化的影响和特点，并观察提高集落刺激因子对干扰素γ抑制骨髓作用的对抗情况。方法采用免疫磁珠法分离纯化骨髓CD34⁺造血干细胞。在体外扩增培养中，以干细胞因子（stem cell factor， SCF）和白介素-3（interleukin-3， IL-3）、粒细胞-巨噬细胞集落刺激因子（granulocyte macrophage-colony stimulating factor， GM-CSF）、粒细胞集落刺激因子（granulocyte-colony stimulating factor， G-CSF）、促红细胞生成素（erythropoietin， EPO）集落刺激因子组合对骨髓干细胞诱导分化，以集落形成单位（colony forming units， CFU）的形成数来评价骨髓分化情况，在体系中加入不同浓度梯度的干扰素γ，观察骨髓集落形成情况。在干扰素γ抑制骨髓的最低浓度下增加集落刺激因子浓度，观察骨髓生长情况。结果患者骨髓CD34⁺细胞质量与正常人相比差异无统计学意义（P>0.05）；不同浓度的干扰素γ对骨髓的抑制程度不同，当干扰素γ浓度提高到10 ng/mL以上时，实验组的集落数目相比于未添加干扰素γ的对照组，差异有统计学意义（P<0.05）；增加培养体系中集落刺激因子浓度可对抗因干扰素γ使骨髓出现的抑制作用情况。结论噬血细胞综合征患者与正常人骨髓质量不存在差异，干扰素γ可以对骨髓生长起抑制作用，提高集落刺激因子浓度可以对抗干扰素γ产生的抑制作用。

关键词: 骨髓集落培养, 噬血细胞综合征, 干扰素γ, 集落刺激因子

Abstract:

Objective To explore whether there are differences between hemophagocytic syndrome patients and normal human bone marrow CD34⁺ cells' quality, study the effect and characteristics of interferon gamma differentiation to the bone marrow, and observe whether improved colony stimulating factor can restrain the inhibition of interferon gamma on bone marrow. Methods Separation and purification of bone marrow CD34⁺ hematopoietic stem cells were performed by immunomagnetic beads method. SCF, IL 3, GM-CSF, G-CSF, EPO colony stimulating factor on differentiation of bone marrow stem cells, the colony forming units (CFU) to evaluate the formation of bone marrow differentiation. Added different concentration gradient of interferon gamma in the system, observation the bone marrow colony formation the situation. Increase in the minimum concentrations interferon gamma inhibition of bone marrow in colony stimulating factor concentration to observe the bone marrow growth situation.Results This study demonstrated no difference in bone marrow CD34⁺ cells compared with normal quality (P> 0.05). The degree of inhibition of interferon gamma in different concentration on bone marrow is different, when interferon gamma concentration increased to more than 10ng/mL, the experimental group colony number difference compared to the control group without the addition of interferon gamma (P<0.05). To increase the training system of colony stimulating factors concentration can be made against the bone marrow suppression of interferon gamma.Conclusion There was no significant difference in bone marrow's quality between HPS patients and normal control. Interferon gamma may inhibit bone marrow's growth. Increased colony stimulating factor concentration may act against interferon gamma production.

Key words: bone marrow colony culture, hemophagocytic syndrome, interferon gamma, colony stimulating factor

中图分类号:

R557

汤然, 王旖旎, 张嘉, 李硕, 王昭. 干扰素γ介导噬血细胞综合征血细胞减少的机制研究[J]. 首都医科大学学报, 2014, 35(5): 545-550.

Tang Ran, Wang Yini, Zhang Jia, Li Shuo, Wang Zhao. Mechanism of interferon gamma mediated hemophagocytic syndrome blood cell reduction[J]. Journal of Capital Medical University, 2014, 35(5): 545-550.

参考文献

[1] Veerbsky J W, Grossman W J. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives[J].Ann Med, 2006,38: 20-31.
[2] Janka G E. Familial and acquired hemophagocytic lymphohistiocytosis[J]. Eur J Pediatr,2007,166(2): 95-109.
[3] 王旖旎, 王昭, 吴林,等. 多中心72例噬血细胞综合征诊疗分析[J]. 中华血液学杂志,2009,30(12): 793-798.
[4] Imran MN, Leng PH, Yang S, et al. Early predictors of mortality in pneumococcal bacteraemia[J].Ann Acad Med Singapore,2005,34(7):426-431.
[5] 蔡大利,高峰,高然,等.异基因外周血造血干细胞联合骨髓移植治疗重型再生障碍性贫血4例报告[J]. 中国医科大学学报,2013,42(4):379-381.
[6] 陈惠仁. 血液科造血干细胞移植技术新进展与发展设想[J]. 解放军医药杂志,2013,25(4):1-5.
[7] 赵卫红. 细胞凋亡的生物学特征. 见赵卫红,寿好长,闫福岭,等主编. 细胞凋亡[M]. 郑州: 河南医科大学出版社,1997,7-11.
[8] Welsh J P, Rutherford T R, Flynn J, et al. In vitro effects of interferon-gamma and tumor necrosis factor-alpha on CD34⁺bone marrow progenitor cells from aplastic anemia patients and normal donors[J]. Hematol J, 2004,5(1):39-46.
[9] Dai C, Krantz S B. Interferon-γ induces upregulation and activetion of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells[J]. Blood, 1999, 93(10): 3309-3316.
[10] Platanias L C. Mechanisms of type-Ⅰ- and type- Ⅱ -interferon-mediated signalling[J]. Nat Rev Immunol, 2005,5(5):375-386.
[11] Chatterjee S, Dutta R K, Basak P, et al. Alteration in marrow stromal microenvironment and apoptosis mechanisms involved in aplastic anemia:an animal model to study the possible disease pathology[J]. Stem Cells Int, 2010,2010:932354.
[12] 陈勤,汤屹,孟力.骨髓呈再生障碍性贫血样表现的低增生性白血病[J]. 临床误诊误治,2012,25(1):11-14.
[13] Wang Y, Wang Z, Wu L, et al. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis[J].Ann Hematol, 2013,92(12):1695-1699.

干扰素γ介导噬血细胞综合征血细胞减少的机制研究

Mechanism of interferon gamma mediated hemophagocytic syndrome blood cell reduction

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	张海萍;连石;朱威. 梅毒患者外周血单核细胞体外诱导树突状细胞的形态学与功能研究[J]. 首都医科大学学报, 2006, 27(6): 727-729.
[2]	徐娟;孙雪静;杨立;田丁. CSF延长慢性粒细胞白血病病理克隆体外培养存活期限作用的研究[J]. 首都医科大学学报, 1997, 18(3): 235-237.